ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657446; 2) Community: the network communities that were significantly associated with the response to NSC 657446; 3) Molecule: the relationships between components within communities and NSC 657446; 4) MDR: the compounds that were significantly associated with the NSC 657446.

NSC Compound Enrichment Correlation
NSC 95099 Bigitalin 0.0388857481216103 0.3121227
NSC 97960 Null 0.0388857481216103 0.14642598
NSC 681239 Bortezomib 0.0422011701988039 0.23508507
NSC 686583 Null 0.0422011701988039 0.56501487
NSC 700893 5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) 0.0422011701988039 -0.26026812
NSC 736739 E2GG, 5,7-bis[(4-methoxybenzyl)amino]-3-isopropylpyrazolo[4,3-d]py rimidine 0.0422011701988039 0.10615547
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0422011701988042 0.76725352
NSC 368697 Benz[a]anthracene-1,7,12(12b-H)-trione, 2,3,4,4a-tetra- hydro-2,3,4a,8,12a-pentahydroxy-3-methyl- 0.0422011701988042 0.73490901
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0422011701988042 0.765612
NSC 641239 Null 0.0422011701988042 0.1221057
Total:73  Current:56    [First] [Prev] [Next] [Last]